Home The crystal structure of N-(7-(4-fluorobenzylidene)-3-(4-fluorophenyl)-3,3a,4,5,6,7-hexahydro-2H-indazole-2-carbonothioyl)benzamide, C28H23F2N3OS
Article Open Access

The crystal structure of N-(7-(4-fluorobenzylidene)-3-(4-fluorophenyl)-3,3a,4,5,6,7-hexahydro-2H-indazole-2-carbonothioyl)benzamide, C28H23F2N3OS

  • Mohammad Hayal Alotaibi , Bakr F. Abdel-Wahab , Obaid Fahad Aldosari , Amany S. Hegazy , Benson M. Kariuki EMAIL logo and Gamal A. El-Hiti EMAIL logo
Published/Copyright: July 19, 2019

Abstract

C28H23F2N3OS, monoclinic, I2/a (no. 15), a = 20.3481(8) Å, b = 10.2647(4) Å, c = 23.6975(11) Å, β = 105.317(5)°, V = 4773.8(4) Å3, Z = 8, Rgt(F) = 0.0489, wRref(F2) = 0.1543, T = 296(2) K.

CCDC no.: 1920669

The crystal structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless block
Size:0.27 × 0.26 × 0.12 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.18 mm−1
Diffractometer, scan mode:SuperNova, ω-scans
θmax, completeness:29.7°, >93% (up to 25.2, >99%)
N(hkl)measured, N(hkl)unique, Rint:39559, 6270, 0.032
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 3722
N(param)refined:264
Programs:CrysAlisPRO [1], SHELX [2], [3], WinGX and ORTEP [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
C10.29286(13)−0.5248(3)0.24724(15)0.1024(9)
C20.30439(13)−0.3979(3)0.25847(12)0.0997(8)
H20.303263−0.3629850.2944250.120*
C30.31807(12)−0.3193(3)0.21515(11)0.0848(6)
H30.326086−0.2309240.2224490.102*
C40.32004(10)−0.3690(2)0.16194(10)0.0709(5)
C50.30884(14)−0.5001(2)0.15249(13)0.0966(8)
H50.310596−0.5365000.1169860.116*
C60.29482(16)−0.5791(3)0.19591(17)0.1128(10)
H60.286958−0.6677870.1894780.135*
C70.33851(10)−0.28349(19)0.11630(9)0.0673(5)
H70.334939−0.3336950.0804340.081*
C80.41031(9)−0.2236(2)0.13749(9)0.0687(5)
H80.426561−0.2372760.1798330.082*
C90.39820(9)−0.08113(19)0.12669(9)0.0656(5)
C100.45453(9)0.0119(2)0.13546(9)0.0672(5)
C110.52028(10)−0.0441(2)0.12734(11)0.0796(6)
H11A0.5581280.0008160.1536530.095*
H11B0.522371−0.0258310.0876940.095*
C120.52988(10)−0.1910(2)0.13815(11)0.0801(6)
H12A0.566937−0.2210340.1227790.096*
H12B0.542544−0.2072320.1799590.096*
C130.46581(10)−0.2688(2)0.10973(10)0.0767(6)
H13A0.452123−0.2532470.0678750.092*
H13B0.474220−0.3612450.1163970.092*
C140.22965(9)−0.16202(18)0.07109(9)0.0630(5)
C150.14029(8)0.00507(18)0.03167(9)0.0616(5)
C16a0.1329(3)0.1480(3)0.0181(3)0.061(2)
C17a0.0671(2)0.1981(6)0.0045(4)0.064(2)
H17a0.0305410.1438610.0045470.076*
C18a0.05606(16)0.3294(6)−0.0090(3)0.081(4)
H18a0.0120570.362997−0.0180940.097*
C19a0.1107(2)0.4106(4)−0.0090(2)0.0849(16)
H19a0.1033390.498396−0.0181250.102*
C20a0.17651(17)0.3604(3)0.0045(2)0.0951(17)
H20a0.2131060.4146610.0044870.114*
C21a0.18759(17)0.2291(3)0.0181(2)0.0785(14)
H21a0.2315920.1955250.0271290.094*
C16Ab0.1313(3)0.1489(5)0.0294(4)0.0619(19)
C17Ab0.0700(3)0.1954(8)−0.0060(5)0.067(2)
H17Ab0.0383560.137217−0.0279680.080*
C18Ab0.0557(3)0.3266(8)−0.0090(4)0.081(4)
H18Ab0.0147290.356630−0.0330240.097*
C19Ab0.1018(3)0.4130(5)0.0235(3)0.0840(17)
H19Ab0.0914790.5013910.0221230.101*
C20Ab0.1631(2)0.3696(4)0.0580(3)0.0930(19)
H20Ab0.1949480.4288090.0788340.112*
C21Ab0.1774(2)0.2374(4)0.0616(3)0.0762(15)
H21Ab0.2184330.2080390.0859590.091*
C220.44478(10)0.1351(2)0.15006(9)0.0687(5)
H220.4006940.1531650.1521230.082*
C230.49145(10)0.2462(2)0.16333(8)0.0669(5)
C240.47536(12)0.3456(2)0.19732(9)0.0787(6)
H240.4355380.3392540.2093830.094*
C250.51670(14)0.4534(2)0.21371(11)0.0895(7)
H250.5052550.5187070.2365920.107*
C260.57466(13)0.4613(2)0.19542(11)0.0864(7)
C270.59160(11)0.3698(2)0.16056(11)0.0842(6)
H270.6308730.3791940.1478880.101*
C280.55015(10)0.2624(2)0.14399(10)0.0762(6)
H280.5614290.2000440.1196460.091*
N10.29616(7)−0.16351(15)0.10253(7)0.0657(4)
N20.33473(7)−0.04890(15)0.10742(7)0.0660(4)
N30.20597(7)−0.03631(15)0.05803(7)0.0664(4)
H3A0.2360860.0242240.0675740.080*
O10.09265(7)−0.06788(14)0.01683(8)0.0878(5)
S10.18611(3)−0.29703(5)0.05185(3)0.0797(2)
F10.27951(10)−0.6031(2)0.28933(9)0.1500(8)
F20.61599(8)0.56611(15)0.21233(8)0.1208(6)
  1. Occupancies: a = 0.521(5), b = 0479(5).

Source of materials

The title compound was synthesized from reaction of an equimolar mixture of 7-(4-fluorobenzylidene)-3-(4-fluorophenyl)-3,3a,4,5,6,7-hexahydro-2H-indazole and benzoyl isothiocyanate in anhydrous ethanol under reflux for 2 h. The crude product was recrystallized from dimethylformamide to give colourless crystals in 82% yield (Mp. 246–248 °C).

Experimental details

All hydrogen atoms were placed in calculated positions and refined using a riding model. The N—H bond was fixed at 0.86 Å (AFIX 43 instruction in SHELXL [2], [3]), with displacement parameters set to 1.2 times Ueq(N). C—H distances for sp2 carbon atoms were set to 0.93 Å (AFIX 43) and Uiso(H) set to 1.2 times Ueq(C). The methine C—H distance was set to 0.98 Å (AFIX 13) and Uiso(H) set to 1.2 times Ueq(C). The methylene C—H distances were set to 0.97 Å (AFIX 23) and Uiso(H) set to 1.2 times Ueq(C). The phenyl ring is disordered and was refined with restrained geometry to form regular hexagons and restrained displacement parameters (DFIX,SIMU) to give final occupancies of 0.479(5) and 0.521(5) for the two components.

Discussion

Many pyrazole derivatives have been synthesized and found to display antimicrobial, antiviral, anti-inflammatory, insecticidal and herbicidal activities [5], [6], [7], [8]. The structure of the title compound has been obtained as part of a study of these materials [9].

The asymmetric unit consists of one molecule of the title compound (see the figure). The molecule consists of two fluorophenyl groups [A (F1, C1—C6) and D (F2, C23—C28)], a hexahydroindazolyl group [B (N1, N2, C7—C13)] and a phenyl group [C (C16—C21)]. Ring C is disordered by a rotation of 35.3(3)° about the C15—C16 bond. The cyclohexane segment (C8—C13) of B assumes a chair conformation. The pyrazolyl ring of B is planar with a maximum deviation of 0.037(3) Å from the least squares plane of the ring. Related structures include cis-1-benzoyl-2-chloroacetyl-4,5-hexamethylenepyrazolidine [10] and 2-benzyl 3-ethyl 6a-methyl 1-(benzoylcarbamothioyl)hexahydrocyclopenta[c] pyrazole-2,3,6a(1H)-tricarboxylate [11] in which the pyrazolyl rings are in envelope conformation. An intramolecular N—H⋯N contact is observed (N3⋯N2 distance of 2.575(2) Å; N3—H3A⋯N2 angle of 112.8°). Two molecules related by inversion symmetry are linked by weak non-classical C—H⋯O interactions (C17⋯O1 distance of 3.427(3) Å and C17—H17⋯O1 angle of 158.4°) to form R22(10) rings. Comparably weak C—H⋯S interactions also occur in the structure with C27⋯S1 distances of 3.676(3) Å and C27—H27⋯S1 angles of 139.7°.

Acknowledgements

The authors would like to thank the Deanship of Scientific Research at Majmaah University for supporting this work under Project Number No. 1440-127, and to Cardiff University for continued support.

References

1. Rigaku Oxford Diffraction. CrysAlis PRO. Rigaku Oxford Diffraction, Yarnton, England (2015).Search in Google Scholar

2. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar

3. Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Cryst. C71 (2015) 3–8.10.1107/S2053229614024218Search in Google Scholar

4. Farrugia, L. J.: WinGX and ORTEP for Windows: an update. J. Appl. Crystallogr. 45 (2012) 849–854.10.1107/S0021889812029111Search in Google Scholar

5. Naim, M. J.; Alam, O.; Nawaz, F.; Alam, M. J.; Alam, P.: Current status of pyrazole and its biological activities. J. Pharm. Bioallied Sci. 8 (2016) 2–17.10.4103/0975-7406.171694Search in Google Scholar

6. Sayed, G. H.; Azab, M. E.; Anwer, K. E.; Abdel Raouf, M.; Negm, N. A.: Pyrazole, pyrazolone and enaminonitrile pyrazole derivatives: Synthesis, characterization and potential in corrosion inhibition and antimicrobial applications. J. Mol. Liq. 252 (2018) 329–338.10.1016/j.molliq.2017.12.156Search in Google Scholar

7. Sidduri, A.; Budd, D. C.; Fuentes, M. E.; Lambros, T.; Ren, Y.; Roongta, V.; Schoenfeld, R. C.; Gillespie, P.; Stevenson, C. S.; Truitt, T.; Qian, Y.: Discovery of novel non-carboxylic acid 5-amino-4-cyanopyrazole derivatives as potent and highly selective LPA1R antagonists. Bioorg. Med. Chem. Lett. 24 (2014) 4450–4454.10.1016/j.bmcl.2014.08.001Search in Google Scholar

8. Faria, J. V.; Vegi, P. F.; Miguita, A. G. C.; Dos Santos, M. S.; Boechat, N.; Bernardino, A. M. R.: Recently reported biological activities of pyrazole compounds. Bioorg. Med. Chem. 25 (2017) 5891–5903.10.1016/j.bmc.2017.09.035Search in Google Scholar

9. Alotaibi, M. H.; Hanan, M. A.; Bakr, F. A.-W.; Amany, H. S.; Kariuki, B. M.; El-Hiti, G. A.: Crystal structure of 5-(5-(4-chlorophenyl)-1-phenyl-1H-pyrazol-3-yl)-N-phenyl-2-amine, C23H16ClN5O. Z. Kristallogr. NCS 234 (2019) 543–545.10.1515/ncrs-2018-0546Search in Google Scholar

10. Kapor, A.; Rakic, S.; Stancic, M.; Simon, L.; Talpas, G. S.; Bernath, G.; Engel, P.: Structure and conformation of cis-benzoyl-2-chloroacetyl-4,5-hexamethylenepyrazolidine: an x-ray study. J. Mol. Struct. 380 (1996) 85–91.10.1016/0022-2860(96)09206-XSearch in Google Scholar

11. Gergely, J.; Morgan, J. B.; Overman, L. E.: Stereocontrolled synthesis of functionalized cis-cyclopentapyrazolidines by 1,3-dipolar cycloaddition reactions of azomethine imines. J. Org. Chem. 71 (2006) 9144–9152.10.1021/jo061537jSearch in Google Scholar PubMed PubMed Central

Received: 2019-04-17
Accepted: 2019-06-04
Published Online: 2019-07-19
Published in Print: 2019-09-25

©2019 Mohammad Hayal Alotaibi et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Articles in the same Issue

  1. Frontmatter
  2. Crystal structure of poly[diaqua-(μ8-1,1′:2′,1′′-terphenyl-3,3′′,4′,5′-tetracarboxylato-κ8O1:O2:O3:O4:O5:O6:O7:O8)dicopper(II)], C22H14Cu2O10
  3. Crystal structure of 2-((1H-benzo[d]imidazol-2-ylimino)methyl)-4,6-di-tert-butylphenol, C22H27N3O
  4. Crystal structure of (4-ethoxynaphthalen-1-yl)(furan-2-yl)methanone, C17H14O3
  5. Crystal structure of 1-nonylpyridazin-1-ium iodide, C13H23N2I
  6. Crystal structure of bis[diaqua(1,10-phenanthroline-κ2N, N′)-copper(II)]diphenylphosphopentamolybdate dihydrate, C36H38Cu2Mo5N4O27P2
  7. The crystal structure of tetrakis(imidazole)-copper(I) hexafluorophosphate, C12H16CuF6PN8
  8. The crystal structure of dimethyl ((3,5-di-tert-butyl-4-hydroxyphenyl)(phenyl)methyl)phosphonate, C23H33O4P
  9. Crystal structure of diaqua-bis(1,10-phenanthroline κ2N,N′)nickel(II) trifluoroacetate- trifluoroacetic acid (1/1), C30H21F9N4NiO8
  10. Crystal structure of 2-(naphthalen-2-yl)-1,8-naphthyridine, C18H12N2
  11. Synthesis and crystal structure of a new polymorph of diisopropylammonium trichloroacetate, C8H16Cl3NO2
  12. Crystal structure of dimethanol-bis(1-((2-methyl-1H-benzo[d]imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κN)-bis(thiocyanato-κN)cadmium(II) C34H34CdN12O2S2
  13. Crystal structure of ethyl 2,2-difluoro-2-(7-methoxy-2-oxo-2H-chromen-3-yl)acetate, C14H12F2O5
  14. The crystal structure of bis[μ2-(N,N-diethylcarbamodithioato-κSSS′)] bis[1′-(diphenylphosphino-κP)-1-cyanoferrocene]disilver(I), C56H56Ag2Fe2N4P2S4
  15. Crystal structure of bis(di-n-butylammonium) tetrachloridodiphenylstannate(IV), C28H50Cl4N2Sn
  16. The crystal structure of poly[(μ5-2-((5-bromo-3-formyl-2-hydroxybenzylidene)amino)benzenesulfonato-κ6O:O:O,O′:O′:O′′)sodium(I)], C13H9O4NSBrNa
  17. Crystal structure of catena-{poly[bis(O,O′-diethyldithiophosphato-S)-(μ2-1,2-bis(4-pyridylmethylene)hydrazine-N,N′)-zinc(II)] di-acetonitrile solvate}, {C20H30N4O4P2S4Zn ⋅ 2 C2H3N}n
  18. Halogen and hydrogen bonding in the layered crystal structure of 2-iodoanilinium triiodide, C6H7I4N
  19. Crystal structure of cyclohexane-1,4-diammonium 2-[(2-carboxylatophenyl)disulfanyl]benzoate — dimethylformamide — monohydrate (1/1/1), [C6H16N2][C14H8O4S2] ⋅ C3H7NO⋅H2O
  20. The synthesis and crystal structure of isobutyl 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-((trifluoromethyl)sulfinyl)-1H-pyrazole-3-carboxylate, C16H13Cl2F6N3O3S
  21. Isolation and crystal structure of bufotalinin — methanol (1/1), C25H34O7
  22. Crystal structure of benzylbis(1,3-diphenylpropane-1,3-dionato-κ2O,O′) chloridotin(IV), C37H29ClO4Sn
  23. Crystal structure of Bis{1-[(benzotriazol-1-yl)methyl]-1-H-1,3-(2-methyl-imidazol)}diiodidocadmium(II), [Cd(C11H11N5)2I2], C22H22N10I2Cd
  24. Crystal structure of 4-isobutoxybenzaldehyde oxime, C11H15NO2
  25. The crystal structure of bis(acetato-κ1O)-bis(N′-hydroxypyrimidine-2-carboximidamide-κ2N,N′)manganese(II) — methanol (1/2), C14H18MnN8O6, 2(CH3OH)′
  26. Crystal structure of poly[bis(μ2-bis(4-(1H-imidazol-1-yl)phenyl)amine-κ2N:N′)-bis(nitrato-κO)cadmium(II)], C36H30CdN12O6
  27. Crystal structure and optical properties of 1,6-bis(methylthio)pyrene, C18H14S2
  28. The crystal structure of hexaquamagnesium(II) bis(3,4-dinitropyrazol-1-ide), C6H14MgN8O14
  29. Halogen bonds in the crystal structure of 4,3:5,4-terpyridine – 1,4-diiodotetrafluorobenzene (1/1), C21H11F4I2N3
  30. Crystal structure and photochromic properties of a novel photochromic perfluordiarylethene containing a triazole bridged pyridine group moiety, C24H18F6N4S2
  31. Crystal structure of bis[(μ3-oxido)-(μ2-(N,N-diisopropylthiocarbamoylthio) acetato-κ2O,O′)-((N,N-diisopropylthiocarbamoylthio)acetato-κO)-bis(di-4-methylbenzyl-tin(IV))], C100H136N4O10S8Sn4
  32. Crystal structure of dibromidobis(4-bromobenzyl)tin(IV), C14H12Br4Sn
  33. The crystal structure of (4Z)-2-[(E)-(1-ethyl-3,3-dimethyl-1,3-dihydro-2H-indol-2-ylidene)methyl]-4-[(1-ethyl-3,3-dimethyl-3H-indolium-2-yl)methylidene]-3-oxocyclobut-1-en-1-olate, C30H32N2O2
  34. The crystal structure of (E)-3-(4-(dimethylamino)styryl)-5,5-dimethylcyclohex-2-en-1-one, C18H23NO
  35. Crystal structure of dihydrazinium 1H-pyrazole-3,5-dicarboxylate, C5H12N6O4
  36. Crystal structure of poly[μ2-1,4-bis((1H-imidazol-1-yl)methyl)benzene-κ2N:N′)-(μ2-4-sulfidobenzoate-κ2O:S)cobalt(II)] dihydrate, C42H44Co2N8O7S2
  37. Crystal structure of 8-(3,4-dimethylbenzylidene)-6,10-dioxaspiro[4.5]decane-7,9-dione, C17H18O4
  38. Crystal structure of 4-(2-bromo-4-(6-morpholino-3-phenyl-3H-benzo[f]chromen-3-yl) cyclohexa-2,5-dien-1-yl)morpholine, C33H31BrN2O
  39. Synthesis and crystal structure of 2-((1-phenyl-3-(thiophen-2-yl)-1H-pyrazol-4-yl)methylene)-2,3-dihydro-1H-inden-1-one, C23H16N2OS
  40. Crystal structure of poly[(μ2-1,1′-(oxybis(4,1-phenylene)bis(1H-imidazole)-κ2N,N′)(μ2-1,3-benzenecarboxylato-κ3O,O′:O′′)zinc(II)] dihydrate, C26H22N4O7Zn
  41. Crystal structure of diaqua-bis(cinnamato-κ2O,O′)zinc(II), C18H18ZnO6
  42. Crystal structure of 2-(prop-2-yn-1-yloxy)-1-naphthaldehyde, C14H10O2
  43. Crystal structure and photochromic properties of 1-(2-methyl-5-phenyl-3-thienyl)-2-{2-methyl-5-[4-(9-fluorenone hydrazone)-phenyl]-3-thienyl}perfluorocyclopentene, C41H26F6N2S2
  44. Hydrothermal synthesis and crystal structure of cylo[tetraaqua-bis(μ2-1,4-bis(1H-benzo[d]imidazol-1-yl)but-2-ene-κ2N:N′)-bis(μ2-4-nitro-phthalate-κ2O,O′)dinickel(II)], C26H23N5O8Ni
  45. Crystal structure of 3-[methyl(phenyl)amino]-1-phenylthiourea, C14H15N3S
  46. Crystal structure of 1-(4-chlorophenyl)-3-[methyl(phenyl)amino]thiourea, C14H14ClN3S
  47. Crystal structure of 2-tert-butyl-1H-imidazo[4,5-b]pyridine, C10H13N3
  48. Crystal structure of 5-carboxy-2-(2-carboxyphenyl)-1H-imidazol-3-ium-4-carboxylate dihydrate, C12H8N2O6⋅2(H2O)
  49. The crystal structure of dichlorido-μ2-dichlorido-(η2-1,4-bis(4-vinylbenzyl)-1,4-diazabicyclo[2.2.2]octane-1,4-diium)dicopper(I), C24H30N2Cu2Cl4
  50. Crystal structure of 4-bromobenzyl (Z)-N-(adamantan-1-yl)morpholine-4-carbothioimidate, C22H29BrN2OS
  51. Crystal structure of (4S,4aS,6aR,6bR,12aS,12bR,14aS,14bR)-3,3,6a,6b,9,9,12a-heptamethyloctadecahydro-1H,3H-4,14b-ethanophenanthro[1,2-h]isochromene-1(6bH)-one, C30H48O2
  52. Crystal structure of 3,5-bis(trifluoromethyl)benzyl (Z)-N′-(adamantan-1-yl)-4-phenylpiperazine-1-carbothioimidate, C30H33F6N3S
  53. The crystal structure of 3-methoxyphenanthridin-6(5H)-one, C14H11NO2
  54. Crystal structure of 4-(5,5-difluoro-1,3,7,9-tetramethyl-3H,5H-5λ4-dipyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinin-10-yl)pyridin-1-ium tetraiodidoferrate(III), C18H19BF2FeI4N3
  55. Crystal structure of 2-(3-methoxyphenyl)-3-((phenylsulfonyl)methyl)imidazo[1,2-a]pyridine, C21H18N2O3S
  56. Crystal structure of [(2-(2-chlorophenyl)-5-ethyl-1,3-dioxane-5-carboxylato-κ2O,O′) (5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II) perchlorate, C29H50Cl2N4NiO8
  57. Crystal structure of (Z)-6-(dimethylamino)-3,3-bis(4-(dimethylamino)phenyl)-2-(2-(quinoxalin-2-ylmethylene)hydrazinyl)-2,3-dihydroinden-1-one, C35H35N7O
  58. 5-Methyl-N′-[5-methyl-1-(4-methylphenyl)-1H-1,2,3-triazole-4-carbonyl]-1-(4-methylphenyl)-1H-1,2,3-triazole-4-carbohydrazide, C22H22N8O2
  59. Crystal structure of 2,3-dichloro-6-methoxyquinoxaline, C9H6Cl2N2O
  60. Synthesis and crystal structure of 7-chloro-2-(ethylsulfinyl)-6-fluoro-3-(1H-pyrazole-1-yl)-4H-thiochromen-4-one, C13H10FN3OS2
  61. Crystal structure of 4-ethylpiperazine-1-carbothioic dithioperoxyanhydride, C14H26N4S4
  62. Crystal structure of 2-(2-(6-methylpyridin-2-yl)naphthalen-1-yl)pyrimidine, C20H15N3
  63. The crystal structure of N′-((1E,2E)-4-(7-methoxy-2-oxo-2H-chromen-8-yl)-2-methylbut-2-en-1-ylidene)-3-methylbenzohydrazide, C23H22N2O4
  64. Crystal structure of catena-poly[(μ2-isophthalato-κ2O:O′)-(2,5-di(pyrazin-2-yl)-4,4′-bipyridine-κ3N,N′,N′′)zinc(II)] — water (2/5), C26H21N6O6.5Zn
  65. Crystal structure of (3E,5E)-3,5-bis(3-nitrobenzylidene)-1-((4-(trifluoromethyl)phenyl)sulfonyl)piperidin-4-one — dichloromethane (2/1), C53H38Cl2F6N6O14S2
  66. Crystal structure of (μ2-oxido)-bis(N,N′-o-phenylenebis(salicylideneiminato))diiron(III) — N,N′-dimethylformamide, C47H43Fe2N4O9
  67. Crystal structure of N1,N3-bis(2-hydroxyethyl)-N1, N1,N3,N3-tetramethylpropane-1,3-diaminium dibromide, C11H28Br2N2O2
  68. Crystal structure of (E)-N-(4-chlorophenyl)-1-(pyridin-2-yl)methanimine, C12H9ClN2
  69. Crystal structure of 8-bromo-6-oxo-2-phenyl-6H-pyrrolo[3,2,1-ij]quinoline-5-carbaldehyde, C18H11BrNO2
  70. Crystal structure of 1,4-bis(2-azidoethyl)piperazine-1,4-diium dichloride trihydrate, C8H18N8Cl2 ⋅ 3 H2O
  71. Crystal structure of (E)-4-bromo-N-(pyridin-2-ylmethylene)aniline, C12H9BrN2
  72. Crystal structure of bis[(2-(3-bromophenyl)-5-methyl-1,3-dioxane-5-carboxylato-κ-O)-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II), C40H60Br2N4NiO8
  73. The crystal structure of (1E,2E)-2-methyl-4-((7-oxo-7H-furo[3,2-g]chromen-9-yl)oxy)but-2-enal O-isonicotinoyl oxime–trichloromethane (3/1), C67H49Cl3N6O18
  74. Crystal structure of 3-(2-ethoxy-2-oxoethyl)-1-methyl-1H-imidazol-3-ium hexafluoridophosphate(V), C8H13F6N2O2P
  75. Crystal structure of bis[(2-(2-bromophenyl)-5-ethyl-1,3-dioxane-5-carboxylato-κO)-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II) hemihydrate C42H65Br2N4NiO8.5
  76. The crystal structure of N-(7-(4-fluorobenzylidene)-3-(4-fluorophenyl)-3,3a,4,5,6,7-hexahydro-2H-indazole-2-carbonothioyl)benzamide, C28H23F2N3OS
  77. The crystal structure of N1,N4-bis(pyridin-3-yl)cyclohexane-1,4-dicarboxamide, C18H20N4O2
  78. Crystal structure of (E)-2-(3,6-bis(ethylamino)-2,7-dimethyl-9H-xanthen-9-yl)-N′-((6-methylpyridin-2-yl)methylene)benzohydrazide – methanol (1/1), C34H37N5O3
  79. Crystal structure of 2-oxo-1-(pyrimidin-5-ylmethyl)-3-(3-(trifluoromethyl)phenyl)-1,2-dihydro-5l4-pyrido[1,2-a]pyrimidin-4-olate, C20H13F3N4O2
  80. Crystal structure of poly[(μ3-9H-carbazole-3,6-dicarboxylato-κ3O1: O2: O3)(μ2-4-(pyridin-4-yl)pyridine-κ2N1:N1′)zinc(II)], C19H11N2O4Zn
  81. Crystal structure of (E)-N′-((1,8-dihydropyren-1-yl)-methylene)picolinohydrazide, C23H15N3O
  82. Crystal structure of catena-poly{[μ2-1,2-bis(diphenylphosphino)ethane]dichloridocadmium(II)}, C26H24CdCl2P2
  83. Crystal structure of the 1:2 co-crystal between N,N′-bis(4-pyridylmethyl)oxalamide and acetic acid as a dihydrate, C14H14N4O2⋅2 C2H4O2⋅2 H2O
  84. Crystal structure of the co-crystal N,N′-bis(3-pyridylmethyl)oxalamide acetic acid (1/2), C14H14N4O2⋅2C2H4O2
  85. Crystal structure of the co-crystal N,N′-bis(4-pyridylmethyl)oxalamide and 2,3,5,6-tetrafluoro-1,4-di-iodobenzene (1/1), C14H14N4O2⋅C6F4I2
  86. Crystal structure of the co-crystal 4-[(4-carboxyphenyl)disulfanyl]benzoic acid–(1E,4E)-1-N,4-N-bis(pyridin-4-ylmethylidene)cyclohexane-1,4-diamine (1/1), C14H10O4S2⋅C18H20N4
  87. Crystal structure of hexacarbonyl-bis(μ2-di-n-propyldithiocarbamato-κ3S,S′:S3S:S:S′)-di-rhenium(I), C20H28N2O6Re2S4
  88. Crystal structure of fac-tricarbonyl-morpholine-κN-(morpholinocarbamodithioato-κ2S,S′)rhenium(I), C12H17N2O5ReS2
Downloaded on 16.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2019-0281/html
Scroll to top button